"The blood-brain barrier (BBB) is the major problem for the treatment of brain diseases because we need to be able to deliver drugs from the vascular system into the central nervous system (CNS).
There are no drug therapies for a wide range of CNS diseases and these include neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases and cerebral ischemia.
Therefore, the focus of this chapter is to discuss how nanoparticles (NPs) can be modified to transport different drug molecules for the treatment of brain diseases.
In essence, NPs’ surface can be functionalized with molecules such as peptides, antibodies and RNA aptamers and these macromolecules can be attached to the receptors present at the BBB endothelial cell surface, which allows the NPs cross the barrier and subsequently deliver pharmaceuticals to the brain for the therapeutic and/or imaging of neurological disorders.
In fact, part of the difficulty in finding an effective treatment for these CNS disorders is that there is not yet an efficient delivery method for drug delivery across the BBB.
However, over the last several years, researches have started to understand some of the design rules to efficiently deliver NPs to the brain."
Guess who those researchers are folks!!!!
The Ones creating NDT Pharmaceuticals Inc., by RM with $MILV
"This field holds the promise to deeply revolutionize the medicine to treatment and therapy areas such as imaging, drug delivery, cell therapy, tissue regeneration and development of new nanomedicine products. Due to its great importance, recent global marketed report expects that the applications of nanotechnology in medicine could reach $528 billion by 2019"
That sounds to me like a good reason to load $MILV since all the news in 1-24 days will be the last time we see sun penny $MILV shares.
News 
Market Data 
Discover 
AI
